Kim Han Na, Fesseha Betiel, Anzaldi Laura, Tsao Allison, Galiatsatos Panagis, Sidhaye Aniket
Division of Endocrinology, Diabetes, & Metabolism, Department of MedicineThe Johns Hopkins University School of Medicine, Baltimore, Md.
The Johns Hopkins University School of Medicine, Baltimore, Md.
Am J Med. 2018 Jan;131(1):102-106. doi: 10.1016/j.amjmed.2017.08.004. Epub 2017 Aug 16.
Type 2 diabetes mellitus is characterized by relative insulin deficiency and insulin resistance. Features suggesting severe insulin resistance include acanthosis nigricans, hyperandrogenism, weight loss, and recurrent hospital admissions for diabetic ketoacidosis. In rare circumstances, hyperglycemia persists despite administration of massive doses of insulin. In these cases, it is important to consider autoimmune etiologies for insulin resistance, such as type B insulin resistance and insulin antibody-mediated extreme insulin resistance, which carry high morbidity and mortality if untreated. Encouragingly, immunomodulatory regimens have recently been published that induce remission at high rates.
METHODS/RESULTS: We describe 3 cases of extreme insulin resistance mediated by anti-insulin receptor autoantibodies or insulin autoantibodies. All cases were effectively treated with an immunomodulatory regimen.
Although cases of extreme insulin resistance are rare, it is important to be aware of autoimmune causes, recognize suggestive signs and symptoms, and pursue appropriate diagnostic evaluation. Prompt treatment with immunomodulators is key to restoring euglycemia in patients with autoimmune etiologies of insulin resistance.
2型糖尿病的特征是相对胰岛素缺乏和胰岛素抵抗。提示严重胰岛素抵抗的特征包括黑棘皮症、高雄激素血症、体重减轻以及因糖尿病酮症酸中毒反复住院。在极少数情况下,尽管使用了大剂量胰岛素,高血糖仍持续存在。在这些病例中,重要的是要考虑胰岛素抵抗的自身免疫病因,如B型胰岛素抵抗和胰岛素抗体介导的极端胰岛素抵抗,若不治疗,其发病率和死亡率都很高。令人鼓舞的是,最近已发表了能诱导高缓解率的免疫调节方案。
方法/结果:我们描述了3例由抗胰岛素受体自身抗体或胰岛素自身抗体介导的极端胰岛素抵抗病例。所有病例均通过免疫调节方案得到有效治疗。
尽管极端胰岛素抵抗病例罕见,但了解自身免疫病因、识别提示性体征和症状并进行适当的诊断评估很重要。对于有胰岛素抵抗自身免疫病因的患者,及时使用免疫调节剂治疗是恢复正常血糖的关键。